SCHEMBL19781967

SCHEMBL19781967

Cc1cc(I)cc(-c2cccnc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.54
CYP3A4 P08684 3/20 0.54
ALDH1A1 P00352 3/20 0.54
CYP1A2 P05177 2/20 0.54
GRM5 P41594 1/20 0.46
MEN1 O00255 1/20 0.44
PSIP1 O75475 1/20 0.44
AXL P30530 1/20 0.44
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
KDM4E B2RXH2 2/20 0.44
TP53 P04637 2/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9654161 0.87 CYP2A6 (0.65) CYP2A6CYP3A4ALDH1A1CYP1A2MEN1
SCHEMBL15810800 0.87 CYP2A6 (0.65) CYP2A6CYP3A4ALDH1A1CYP1A2MEN1
SCHEMBL12070458 0.87 CYP2A6 (0.65) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5
SCHEMBL10262832 0.87 CYP2A6 (0.65) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5
SCHEMBL16547005 0.87 CYP2A6 (0.65) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5
SCHEMBL27430951 0.83 CYP2A6 (0.60) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5
SCHEMBL22693745 0.83 CYP2A6 (0.60) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5
SCHEMBL12131368 0.83 CYP2A6 (0.60) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5
SCHEMBL21117061 0.81 CYP19A1 (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2MEN1
SCHEMBL10263457 0.81 CYP19A1 (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10897014-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-19 US disclosed
US-20180019410-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10897014-B2 Heterocyclic compound and organic light-emitting device including the same SUN2, CRY1, CRY2 CYP2A6 494/4885CYP3A4 16/4885ALDH1A1 317/4885
US-20180019410-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SUN2, CRY1, CRY2 CYP2A6 494/4885CYP3A4 16/4885ALDH1A1 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.